Glenmark launches generic Lacosamide Injection USP in US Market
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision
The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres
Targeting deadly drug-resistant acinetobacter infections
Subscribe To Our Newsletter & Stay Updated